HTT

HTT Overview

English NameHuntingtinApproved Drugs0
Drugs in Clinical Trials10Target SynonymHuntingtin,HD protein,HD,HTT,Huntington Disease Protein,IT15,Huntingtin (Huntington Disease),LOMARS,Huntingtin Protein
Highest Development StagePhase 3 Clinical
English NameHuntingtin
Target SynonymHuntingtin,HD protein,HD,HTT,Huntington Disease Protein,IT15,Huntingtin (Huntington Disease),LOMARS,Huntingtin Protein
Approved Drugs0
Drugs in Clinical Trials10
Highest Development StagePhase 3 Clinical

HTT Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag & MBP Tag (1)

  • Conjugate

    Unconjugated (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
HTT-H51M5
Human
E. coli
Human HTT Protein, MBP,His Tag (MALS verified)
Total: 1
  • 1

HTT Background

Huntingtin is the protein coded for by the HTT gene. Autosomal dominant mutation in the Huntingtin (Htt) protein is the cause of Huntington’s Disease (HD). In HD, the polyglutamine (polyQ) domain in the N-terminal sequenceof the protein is expanded beyond a threshold of 36 glutamines. mutant polyQ expansion strongly correlates in an inverse manner to disease age of onset.

HTT Synonyms

HTT,Htt,Huntingtin

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
TominersenRG-6042; RO-7234292; ISIS-443139Phase 3 ClinicalIonis Pharmaceuticals IncHuntington Disease
Details
SKY-0515SKY-0515Phase 3 ClinicalSkyhawk Therapeutics IncHuntington Disease; Nervous System Diseases
Details
VotoplamPTC-518; PTC518Phase 3 ClinicalPtc Therapeutics IncHuntington Disease
Details
WVE-003WVE-003Phase 2 ClinicalWave Life Sciences LtdHuntington Disease
Details
NA-841NA-841; NA841Phase 2 ClinicalBiomed Industries IncHuntington Disease
Details
SPK-10001SPK-10001; RG-6662; HTT miRNA GTPhase 2 ClinicalSpark Therapeutics IncHuntington Disease
Details
ER-2001ER-2001; ER2001Phase 2 ClinicalShenzhen Aima Biotechnology Co LtdHuntington Disease
Details
ARO-HTTARO-HTT; SRP-1005Phase 1 ClinicalArrowhead Pharmaceuticals IncHuntington Disease
Details
ALN-HTT-02ALN-HTT-02; ALN-HTT02Phase 1 ClinicalAlnylam Pharmaceuticals IncHuntington Disease
Details
PTC-607PTC-607Phase 1 ClinicalPtc Therapeutics IncHuntington Disease
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호